OTC · Medical - Instruments & Supplies

LifePoint, Inc. (LFPI) Stock

$0.00 OTC: LFPI Healthcare

LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening.

Valuation

MetricValue
Price$0.00
Market Cap$31294
P/E Ratio0.00
P/B Ratio0.01
P/S Ratio-1.69
EPS (TTM)$-0.36
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-250.00%
ROA-166.67%
ROCE-115.19%
Gross Margin385.72%
Operating Margin
Net Margin
Debt/Equity0.00
Current Ratio3.00

Annual Financials (USD)

Metric19992000200120022003
Revenue$0$0$0$0$0
Operating Profit$-4.0M$-8.0M$-13.0M$-16.0M$-7.0M
Net Profit$-4.0M$-7.0M$-13.0M$-16.0M$-15.0M
EPS$-0.26$-0.23$-0.40$-0.45$-0.36
Op Margin-9401.3%-32201.3%40514.8%

Balance Sheet (USD)

Metric19992000200120022003
Total Assets$10.0M$9.0M$8.0M$6.0M$9.0M
Total Liabilities$1.0M$2.0M$3.0M$6.0M$2.0M
Cash$9.0M$6.0M$3.0M$0$4.0M
Borrowings$0$1.0M$1.0M$2.0M$0

Cash Flow (USD)

Metric19992000200120022003
Operating Cash Flow$-4.0M$-7.0M$-12.0M$-15.0M$-7.0M
Investing Cash Flow$0$-1.0M$-2.0M$-2.0M$0
Financing Cash Flow$8.0M$4.0M$5.0M$11.0M$11.0M
Net Cash Flow$5.0M$-3.0M$-3.0M$-3.0M$4.0M
Free Cash Flow$-4.0M$-8.0M$-13.0M$-15.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.23
FCF Yield-22733.96%
Quick Ratio1.75
Interest Coverage-24.63
Return 1Y1400.00%
Return 3Y200.00%
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AFIBAcutus Medical, Inc. $0.00 0.00 $2991 0.00%
EVLOEvelo Biosciences, Inc. $0.00 0.00 $1898 0.00%
HLTTHealthtech Solutions Inc. $0.00 0.00 $10663 0.00%
ICCTiCoreConnect Inc. $0.00 0.00 $5365 0.00%
OLMMOneLife Technologies Corp. $0.00 0.00 $10052 0.00%

About LifePoint, Inc.

LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical services (ambulances), retail pharmacies, public safety organizations, and the home healthcare sector. Established in 1992, the company was formerly known as US Drug Testing, Inc. until it adopted its current name, LifePoint, Inc., in February 1998. Its headquarters are situated in Ontario, California.

LifePoint, Inc. (LFPI) stock trades at $0.00 with a market capitalization of $31294. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.01, price-to-sales of -1.69. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, LifePoint, Inc. generates a return on equity (ROE) of -250.00%, return on capital employed of -115.19%.

Official website: www.lifepointinc.org

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides